NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹271 Cr | ₹208 Cr | ₹143 Cr | ₹124 Cr | ₹103 Cr |
What is the latest Total Non-Current Assets ratio of NGL FINECHEM ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹271 Cr |
| Mar2025 | ₹208 Cr |
| Mar2024 | ₹143 Cr |
| Mar2023 | ₹124 Cr |
| Mar2022 | ₹103 Cr |
How is Total Non-Current Assets of NGL FINECHEM Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹271 Cr | 30.52 | |
| Mar2025 | ₹208 Cr | 45.59 | |
| Mar2024 | ₹143 Cr | 14.83 | |
| Mar2023 | ₹124 Cr | 20.29 | |
| Mar2022 | ₹103 Cr | - | |
Compare Total Non-Current Assets of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,671.0 Cr | -2.5% | -12.5% | 66.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -2.5% |
-12.5% |
66.6% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses